Dan Wychulis Named CEO of LifeSci Capital

NEW YORK, July 1, 2024 (GLOBE NEWSWIRE) — LifeSci Capital LLC, a research-driven investment bank focused on life sciences, today announces the appointment of Dan Wychulis as Chief Executive Officer, effective immediately.

Mr. Wychulis brings a wealth of experience in capital markets to LifeSci Capital, with a broad background spanning equities, corporate finance, research, institutional sales, corporate access, strategy and business development. Prior to joining LifeSci Capital, he spent eight years at BTIG, most recently as Co-Head of Global Equities and previously as Head of U.S. Franchise Strategy and Sales. He most recently served on BTIG’s Executive Committee, Global Operating Committee, Capital Markets Advisory Committee and Engagement Committee. Prior to BTIG, he spent 15 years at JMP Group, where he led the firm’s institutional equity research sales team, held senior positions in institutional sales and was Vice President of Corporate Finance. Mr. Wychulis began his Wall Street career in corporate finance at Sandler O’Neill & Partners, focusing on mergers and acquisitions. He holds a Bachelor of Science in Public Administration with a concentration in international relations from Georgetown University.

“We are excited to welcome Dan to our team. His extensive financial industry expertise and strong relationships will be invaluable as we continue to expand our presence in the life sciences sector,” said Dr. Andrew McDonald, co-founder of LifeSci Capital. “LifeSci Capital is on a solid growth trajectory and I am confident that Dan is the right leader to further enhance our offering to corporate clients and investors.”

Mr. Wychulis commented, “LifeSci Capital has established itself as a truly diversified healthcare finance firm. This is an important segment within the LifeSci Partners network of firms that collectively deliver high-quality professional services to life sciences companies from start to finish. I am excited to build on this success and lead the company to the next level of growth. I look forward to working closely with this talented team to drive innovation, execute strategic initiatives and deliver exceptional value to our clients.”

LifeSci Capital continues to strengthen its position as a leading banking partner in the mid-market healthcare sector, helping to raise over $6.5 billion across 35 financing transactions over approximately the last 18 months.

LifeSci Capital (www.lifescicapital.com) (Member: FINRA/SIPC) is a research-based investment bank registered with the U.S. Securities and Exchange Commission (“SEC”) and the Financial Industry Regulatory Authority (“FINRA”) that provides corporate financing services , strategic consulting and capital research for corporate and institutional investors. The company’s highly talented team specializes exclusively in life sciences companies that discover, develop and commercialize innovative products, and is uniquely positioned to work closely with corporate clients to establish and execute their financial and strategic initiatives. LifeSci Capital’s research product, led by its Alpha Series and KOL Series offerings, is highly differentiated and provides the investment community with a deep understanding of companies across therapeutic indications that lie both within and beyond our universe of coverage.

The story continues

LifeSci Partners LifeSci is a leading provider of strategic healthcare advisory services in the areas of investor relations, strategic consulting, strategic partnerships, communications, capital markets services, mutual fund and venture capital investments, executive search and on-demand talent with global operations in North America, Europe, Israel and Asia. The firm has offices in New York, Boston, San Francisco/Silicon Valley, Chicago, Charlotte, London, Geneva, Paris, Milan and Tel Aviv. LifeSci leverages global relationships and local knowledge in multiple territories around the world to deliver high-value services to clients. The firm has an experienced team drawn from diverse Wall Street, scientific and communications backgrounds to successfully plan and implement strategic programs for public and private life science companies of all sizes and stages.

Communication

Dr. Andrew McDonald
LifeSci Capital, LLC
Phone: 646-597-6987
[email protected]

Michał Ryś
LifeSci Capital, LLC
Phone: 646-597-6979
[email protected]

Additional information about LifeSci Capital and its services can be found at www.lifescicapital.com.